JGJiawei Guo

Jiawei Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiawei Guo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Siyao Yang

    The Medical Record Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China

    4 shared publications
  • Wencui Li

    Hand and Foot Surgery Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China

    3 shared publications
  • Daping Wang

    Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China

    2 shared publications
  • Jianquan Liu

    Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China

    2 shared publications
  • Aozhengzheng Dong

    Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China

    1 shared publication
  • Bin Jiang

    Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen 518028, China

    1 shared publication

Latest Publications

  • Open Access

    Influencing factors on mechanical properties of tendon-suture system during graft preparation: a multiple linear regression analysis

    by Aozhengzheng Dong, Changliang Ma, Siyao Yang, Jiawei Guo, Zhe Zhao

    Guiding the graft through the bone tunnel is a crucial step during arthroscopic ligament reconstruction, which is the preferred surgical treatment for ante

  • Open Access

    Chondrocyte Senescence in Osteoarthritis: Potential Targets and Pharmacological Interventions

    by Dunyong Tan, Jiawei Guo, Tianyu Wang, Siyao Yang, Jianquan Liu, Daping Wang, Wencui Li

    Purpose: This review aims to elucidate the mechanisms underlying chondrocyte senescence in osteoarthritis (OA) from 4 core perspectives: extracellular inflammation, mechanical overload and stress, intracellular metabolic and signaling dysregulation, and genetics-related alterations. It further summarizes emerging therapeutic strategies targeting chondrocyte senescence to address the unmet clinical need for disease-modifying OA interventions. Findings: Accumulating evidence indicates that chondrocyte senescence drives OA progression through multiple interconnected mechanisms. These include amplification of inflammation and extracellular matrix degradation via the senescence-associated secretory phenotype (SASP), disruption of anabolic-catabolic homeostasis, dysregulation of mechanotransduction pathways under excessive mechanical load, and reshaping of intracellular metabolism and redox balance. Additional contributing mechanisms involve epigenetic dysregulation, non-coding RNA–mediated gene modulation, and impaired autophagy. Therapeutic approaches under preclinical or clinical investigation encompass senolytic and senomorphic agents, chondroprotective biological materials, genetic or RNA-based interventions, as well as strategies targeting SASP modulation and extracellular microenvironment repair. Conclusions: Chondrocyte senescence serves as a central convergent mechanism in OA pathogenesis and a promising target for disease-modifying therapies. Advances in mechanistic understanding and senescence-targeted interventions offer new avenues for translational innovation, though critical challenges related to specificity, safety, and long-term efficacy require further resolution.


  • Open Access

    ACADL and ADH1B signify ketone body metabolic reprogramming in osteoarthritic synovium: insights from bioinformatics and animal model studies

    by Kuokuo Li, Bingshu Chen, Xun Yang, Yijun Yuan, Siyao Yang, Jinteng Liu, Jiawei Guo, Meng He

    Introduction: Osteoarthritis (OA) is characterized by articular degeneration and chronic joint pain, partly resulting from synovial inflammation. Accumulating evidence suggests that alterations in the synovial ketone body metabolism (KBM) are closely associated with OA pathogenesis. This study aimed to investigate the metabolic changes in synovial tissues to optimize the treatment of clinical OA. Methods: Analysis of OA and normal control synovial transcriptomic datasets extracted from the Gene Expression Omnibus (GEO) identified 808 differentially expressed genes (DEGs). These DEGs were integrated with KBM-related genes from the metabolic databases, yielding 50 candidates related to OA progression. Following enrichment analysis, protein-protein interaction network construction via STRING, and machine learning with expression analysis, two genes were identified as OA biomarkers: ACADL, encoding long-chain acyl-CoA dehydrogenase and ADH1B , alcohol dehydrogenase 1 B. Results: The nomogram based on these data revealed high accuracy in the training and validation sets. Functional analysis revealed that these genes function in lipid oxidation, a process critical for synovial cell energy metabolism, as well as in the redox balance that prevents oxidative stress from worsening OA inflammation. Immune infiltration analysis revealed that their expression significantly correlated with 21 immune subtypes, including pro-inflammatory M1 macrophages and Th17 cells, which drive synovial inflammation. Molecular docking analysis identified progesterone and fomepizole as potential agents with satisfactory affinities for ACADL and ADH1B , respectively. Assessment of mouse models of OA confirmed a significant reduction in the synovium at the protein level. Discussion: ACADL and ADH1B link KBM abnormalities to immune dysregulation in the OA synovium. The nomogram enables the precise early diagnosis of OA, and progesterone and fomepizole are promising targeted therapies. These findings deepen the current understanding of OA pathogenesis and support the advancement of personalized treatments for clinical translation.

  • Open Access

    Sinus Tarsi Morphometry Is Correlated with Flatfoot Severity on Weight-Bearing CT

    by Bingshu Chen, Xing Gao, Ying Xu, Tianyuan Zhao, Siyao Yang, Yuan Liu, Bin Jiang, Xihan Zhou, Xiaoqiang Chen, Wencui Li, et al.

    Background: Flexible flatfoot is a common musculoskeletal disorder in adolescents, which is characterized by a collapsed longitudinal arch. A common surgery like subtalar arthroereisis depends on the implant in sinus tarsi. Optimal match between them can potentially avoid postoperative pain and obtain improved prognosis. Investigations into anatomical morphology of sinus tarsi by weight-bearing CT (WBCT) may unveil the pathogenesis and facilitate the treatment of flexible flatfoot. Methods: This retrospective study included 28 control cases and 42 flatfoot cases. The sinus tarsi length (STL), the sinus tarsi width (STW), the angle between its long axis and the horizontal line (ST-H angle), the sinus tarsi angle (ST angle), and the tibial width were measured. We also calculated two ratios (STL/tibia width and STW/tibia width) to standardize individual differences. Data analysis was conducted via mean/median comparisons and subsequent linear regression. Results: The STL and the STL/tibia width were significantly greater in the flatfoot group (25.73 ± 3.50 vs. 23.09 ± 3.77 mm, p = 0.004; 0.90 ± 0.15 vs. 0.81 ± 0.14, p = 0.009). The ST angle was significantly smaller in the flatfoot group by an average of 4.63° (13.20° vs. 17.83°, p < 0.001). Linear regression revealed that female gender and smaller ST angle were significantly correlated with higher Meary angle, while smaller ST angle and greater STL/tibia width were significantly correlated with lower Pitch angle (p = 0.002, p = 0.007; p = 0.003, p = 0.004). No statistical predictive effects were observed for the other variables. Conclusions: The ST angle and STL/tibia width may serve as auxiliary parameters for implant selection in subtalar arthroereisis to improve sizing match within the sinus tarsi.


  • Open Access

    Loadless Tendon Explant Model Exhibits Spontaneous Degradative Phenotypes: An In Vitro Study of Human Tendons

    by Bing Shu Chen, Yi Jun Yuan, Yi Long Wang, Si Yao Yang, Wen Cui Li, Jia Wei Guo

    Background: Although the tendon explant model has been gradually recognized for simulating tendon characteristics in vitro, there is still no consensus on a standardized culture protocol. Recently, tendon explants have been applied to senescence-related research but whether their own changes affected the credibility of the conclusions was not confirmed. Therefore, this study aimed to systematically evaluate the reliability of the loadless tendon explant model by characterizing its dynamic macroscopic morphological and molecular biological changes during culture. Methods: This study collected surgical samples from patients as loadless tendon explants for culture and conducted molecular biology and cytology tests once every 3 days within 15 days. Both their macroscopic and microscopic changes were recorded and analyzed, with each compared to the corresponding parameters at day 0. Results: Loadless tendon explants spontaneously underwent progressive disintegration, leading to the collapse of the original dense structure. Consistently, the collagen fibers also gradually became loose and fractured, contributing to a significant decrease of collage density from day 9. In addition, the senescence and apoptosis markers P21 and Caspase 3 increased over time, and there were statistically significant differences starting from day 6, respectively. The main intrinsic component, Collagen I, and the main catabolic enzyme, metalloproteinase 13 (MMP 13), could hardly be detected since day 3. During the daily evaluations from day 0 to day 4, Collagen I gradually decreased and was barely detectable by day 3, whereas MMP 13 increased on day 1 followed by a rapid decline since day 2. Conclusions: These results indicate that loadless tendon explants rapidly degrade and lose matrix integrity, with their spontaneous changes compromising the reliability of research conclusions related to senescence and apoptosis. Therefore, further optimization is still required before a well-established protocol is applied.

  • Open Access

    Comparative study of chitosan-based liquid dressing and recombinant human epidermal growth factor on acute limb skin wound healing: A randomized controlled trial

    by Dunyong Tan, Jiawei Guo, Xiaoqiang Chen, Jianquan Liu, Siyao Yang, Daping Wang, Wencui Li


  • Top Cited Papers
    Open Access

    Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression

    by Hao Zhang, Lipeng Wang, Jin Cui, Sicheng Wang, Yafei Han, Hongda Shao, Cheng Wang, Yan Hu, Xiaoqun Li, Qirong Zhou, et al.

    Abnormal subchondral bone remodeling featured by overactivated osteoclastogenesis leads to articular cartilage degeneration and osteoarthritis (OA) progression, but the mechanism is unclear. We used lymphocyte cytosolic protein 1 ( Lcp1 ) knockout mice to suppress subchondral osteoclasts in a mice OA model with anterior cruciate ligament transection (ACLT), and Lcp1 −/− mice showed decreased bone remodeling in subchondral bone and retarded cartilage degeneration. For mechanisms, the activated osteoclasts in subchondral bone induced type-H vessels and elevated oxygen concentration, which ubiquitylated hypoxia-inducible factor 1 alpha subunit (HIF-1α) in chondrocytes and led to cartilage degeneration. Lcp1 knockout impeded angiogenesis, which maintained hypoxia environment in joints and delayed the OA progression. Stabilization of HIF-1α delayed cartilage degeneration, and knockdown of Hif1a abolished the protective effects of Lcp1 knockout. Last, we showed that Oroxylin A, an Lcp1- encoded protein l -plastin (LPL) inhibitor, could alleviate OA progression. In conclusion, maintaining hypoxic environment is an attractive strategy for OA treatment.